Radnor Capital Management, LLC Bristol Myers Squibb CO Transaction History

Radnor Capital Management, LLC

$673 Million
Q3 2024

A detailed history of Radnor Capital Management, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Radnor Capital Management, LLC holds 89,466 shares of BMY stock, worth $4.86 Million. This represents 0.69% of its overall portfolio holdings.

Number of Shares

89,466

Holding current value

$4.86 Million

% of portfolio

0.69%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 30, 2024	BUY	$39.66 - $51.75 $3.55 Million - $4.63 Million	89,466 New	89,466 $4.63 Million
Q1 2024 Apr 11, 2024	SELL	$47.98 - $54.4 $8,108 - $9,193	-169 Reduced 0.25%	66,823 $3.62 Million
Q4 2023 Jan 11, 2024	SELL	$48.48 - $57.85 $141,270 - $168,574	-2,914 Reduced 4.17%	66,992 $3.44 Million
Q3 2023 Oct 12, 2023	BUY	$57.89 - $64.73 $4.05 Million - $4.53 Million	69,906 New	69,906 $4.06 Million
Q1 2023 Apr 06, 2023	BUY	$65.71 - $74.53 $182,673 - $207,193	2,780 Added 5.34%	54,866 $3.8 Million
Q4 2022 Jan 09, 2023	SELL	$68.48 - $81.09 $2,396 - $2,838	-35 Reduced 0.07%	52,086 $4.03 Million
Q3 2022 Oct 12, 2022	SELL	$0.13 - $76.84 $5 - $3,073	-40 Reduced 0.08%	52,121 $3.71 Million
Q2 2022 Jul 11, 2022	BUY	$72.62 - $79.98 $165,210 - $181,954	2,275 Added 4.56%	52,161 $4.02 Million
Q1 2022 Apr 25, 2022	SELL	$61.48 - $73.72 $1,844 - $2,211	-30 Reduced 0.06%	49,886 $3.64 Million
Q4 2021 Jan 20, 2022	BUY	$53.63 - $62.52 $2.68 Million - $3.12 Million	49,916 New	49,916 $3.11 Million
Q3 2021 Oct 26, 2021	SELL	$59.17 - $69.31 $2.82 Million - $3.31 Million	-47,716 Closed	0 $0
Q2 2021 Jul 21, 2021	BUY	$61.91 - $67.42 $9,596 - $10,450	155 Added 0.33%	47,716 $3.19 Million
Q1 2021 Apr 26, 2021	BUY	$59.34 - $66.74 $167,635 - $188,540	2,825 Added 6.31%	47,561 $3 Million
Q4 2020 Jan 13, 2021	BUY	$57.74 - $65.43 $33,489 - $37,949	580 Added 1.31%	44,736 $2.78 Million
Q3 2020 Nov 02, 2020	SELL	$57.43 - $63.64 $57,430 - $63,640	-1,000 Reduced 2.21%	44,156 $2.66 Million
Q2 2020 Jul 28, 2020	BUY	$54.82 - $64.09 $35,304 - $41,273	644 Added 1.45%	45,156 $2.68 Million
Q1 2020 Apr 07, 2020	SELL	$46.4 - $67.43 $17,724 - $25,758	-382 Reduced 0.85%	44,512 $2.48 Million
Q3 2019 Oct 07, 2019	BUY	$42.77 - $50.71 $29,939 - $35,497	700 Added 1.58%	44,894 $2.28 Million
Q2 2019 Jul 18, 2019	BUY	$44.62 - $49.34 $155,054 - $171,456	3,475 Added 8.53%	44,194 $2 Million
Q1 2019 Apr 25, 2019	BUY	$45.12 - $53.8 $86,856 - $103,565	1,925 Added 4.96%	40,719 $1.94 Million
Q4 2018 Jan 16, 2019	BUY	$48.76 - $63.23 $48,760 - $63,230	1,000 Added 2.65%	38,794 $2.02 Million
Q3 2018 Oct 04, 2018	BUY	$55.19 - $62.25 $176,608 - $199,200	3,200 Added 9.25%	37,794 $2.35 Million
Q2 2018 Jul 10, 2018	SELL	$50.53 - $62.98 $85,901 - $107,066	-1,700 Reduced 4.68%	34,594 $1.91 Million
Q1 2018 Apr 20, 2018	SELL	$59.92 - $68.98 $17,976 - $20,694	-300 Reduced 0.82%	36,294 $2.3 Million
Q2 2017 Aug 09, 2017	BUY	N/A	36,594	36,594 $2.04 Million

Others Institutions Holding BMY

# of Institutions

2,449

Shares Held

1.51B

Call Options Held

29.7M

Put Options Held

32.1M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $115B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Radnor Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Radnor Capital Management, LLC with notifications on news.

Account

Radnor Capital Management, LLC Bristol Myers Squibb CO Transaction History